Rodrigo Ezequiel Dominguez

Dr. Rodrigo Ezequiel Dominguez

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1993 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
MGMaria Isabel LOZA GARCIA
Maria Isabel LOZA GARCIA
FSFerran Sanz
Ferran Sanz
MCM. I. Cadavid
M. I. Cadavid
MHM. Honrubia
M. Honrubia
FOF. Orallo
F. Orallo
MVM. C. Villaverde
M. C. Villaverde

20 September 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
WGWalter Damian Guerra
Walter Damian Guerra
EOEmmanuel Odella
Emmanuel Odella
KCKai Cui
Kai Cui
MSMaxim Secor
Maxim Secor
Rodrigo Ezequiel DominguezRodrigo Ezequiel Dominguez
Rodrigo Ezequiel Dominguez
AMAna L. Moore
Ana L. Moore
The electrochemical properties of a bioinspired naphthoquinone bearing an intramolecular hydrogen-bonded carboxylic acid are explained by a combination of PCET and ET processes.

3 July 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
OOOscar Osorio-Perez
Oscar Osorio-Perez
NNNgan Anh Nguyen
Ngan Anh Nguyen
LDLandon Ray Denham
Landon Ray Denham
Asher HendricksAsher Hendricks
Asher Hendricks
Rodrigo Ezequiel DominguezRodrigo Ezequiel Dominguez
Rodrigo Ezequiel Dominguez
EFErica Forzani
Erica Forzani
Ketones, which are key biomarkers of fat oxidation, are relevant for metabolic health maintenance and disease development, making continuous monitoring essential. In this study, we introduce a novel colorimetric sensor designed for potential continuous acetone detection in biological fluids. The sensor features a polydimethylsiloxane (PDMS) shell that encapsulates a sensitive and specific liquid-core acetone-sensing probe. The microsphere sensors were characterized by evaluating their size, PDMS shell thickness, colorimetric response, and sensitivity under realistic conditions, including 100% relative humidity (RH) and CO2 interference. The microsphere size and sensor sensitivity can be controlled by modifying the fabrication parameters. Critically, the sensor showed high selectivity for acetone detection, with negligible interference from CO2 concentrations up to 4%. In addition, the sensor displayed good reproducibility (CV < 5%) and stability under realistic storage conditions (over two weeks at 4 °C). Finally, the accuracy of the microsphere sensor was validated against a gold standard gas chromatography-mass spectrometry (GC-MS) method using simulated and real breath samples from healthy individuals and type 1 diabetes patients. The correlation between the microsphere sensor and GC-MS produced a linear fit with a slope of 0.948 and an adjusted R-squared value of 0.954. Therefore, the liquid-core microsphere-based sensor is a promising platform for acetone body fluid analysis.

28 January 2026 in Sensors
Verified
Journal Article
Open access
PDF file
PHPiyush Hota
Piyush Hota
APAdithya Shyamala Pandian
Adithya Shyamala Pandian
Rodrigo Ezequiel DominguezRodrigo Ezequiel Dominguez
Rodrigo Ezequiel Dominguez
MMManni Mo
Manni Mo
BFBo Fu
Bo Fu
EFErica Forzani
Erica Forzani
Acute kidney injury (AKI) affects thousands of hospitalized patients annually, yet early detection remains challenging as serum creatinine elevation lags behind clinical deterioration. Decreased urine output (UO) represents a key diagnostic criterion of AKI, sometimes manifesting hours before biochemical changes; however, current manual monitoring methods are labor-intensive and prone to error. Here, we developed and validated a simple, cost-effective automated urine flow meter using non-contact optical sensors, a peristaltic pump, and microcontroller-based automation for precise, real-time monitoring of urine output in clinical settings, named P-meter. Three successive prototypes (V1, V2, V3) were validated against gold-standard gravimetric measurements over 285 h of testing during animal experiments that required bladder catheterization. Iterative refinement addressed miniaturization challenges, fluid dynamics optimization, and sensor positioning to achieve progressively improved accuracy. The optimized V3 prototype demonstrated further enhanced volumetric precision, stability, and flow accuracy with near-unity linearity vs. reference method (R2 = 0.9889), minimal bias (mean error −0.1 mL), and 94.18% agreement within confidence limits (n = 86), outperforming the initial V1 prototype (R2 = 0.9971, mean error −1.69 mL, n = 207) and intermediate V2 design (R2 = 0.9941, mean error 3.63 mL, n = 390), primarily in terms of reduced bias and improved agreement. The P-meter offers accurate urine output monitoring at a lower cost than commercial systems, facilitating its use in early AKI detection and thereby improving patient outcomes.

7 July 2026 in Nutrition & Diabetes
Verified
Journal Article
Open access
ANAnh Ngan Nguyen
Anh Ngan Nguyen
OOOscar Osorio-Perez
Oscar Osorio-Perez
DJDavid Jackemeyer
David Jackemeyer
ETEliana Terrera
Eliana Terrera
SVShaun Victor
Shaun Victor
EFErica Forzani
Erica Forzani
We present the first receiver operating characteristic (ROC) diagnostic analysis of skin-excreted acetone as a biomarker of ketosis. In an 8-week controlled crossover pilot study (n = 16), we evaluated the ability of skin-emitted acetone to differentiate metabolic ketosis from non-ketosis states. Non-ketosis was established via a normal diet/energy balance, while ketosis was induced through dietary and energy manipulations, including ketogenic diets and negative energy balances. Alongside skin acetone concentration and excretion rate, we quantified a comprehensive set of ketone body parameters for comparative diagnostic purposes, including breath acetone concentration and excretion rate, blood beta-hydroxybutyrate concentration, urine beta-hydroxybutyrate concentration and excretion rate, and urine acetoacetate concentration and excretion rate. Blood BHB (mM) served as the clinical benchmark for ketosis. ROC curves were generated to evaluate the diagnostic performance of each biomarker in distinguishing between ketosis and non-ketosis. Both breath and skin acetone excretion rates achieved an area under the curve (AUC) of 0.83, outperforming several other ketone biomarkers. Similarly, breath acetone and skin acetone concentrations also exhibited AUCs of 0.82 and 0.83, respectively. In comparison, blood beta-hydroxybutyrate concentration and urine acetoacetate excretion rate both showed an AUC of 0.81, while urine beta-hydroxybutyrate excretion rate and concentration achieved AUCs of 0.66 and 0.68, respectively. Furthermore, breath and skin acetone excretion rates were systematically compared within and across participants. The correlation between the two reinforces the significance of skin acetone as a body ketone biomarker that diffuses through the skin, representing the body's acetone concentrations. Overall, the results highlight the potential of skin acetone excretion rate as a reliable, non-invasive biomarker of ketosis, with diagnostic accuracy comparable to that of blood-based standards, offering significant promise for continuous, wearable metabolic monitoring in clinical and health settings.

31 July 2026 in Analytica
Verified
Journal Article
Open access
PDF file
Rodrigo Ezequiel DominguezRodrigo Ezequiel Dominguez
Rodrigo Ezequiel Dominguez
VYValerie Yang
Valerie Yang
AFAshley Fu
Ashley Fu
ECEdward H. Cheng
Edward H. Cheng
MTMirna Terrera
Mirna Terrera
EFErica Forzani
Erica Forzani
Urinary urea is a key biomarker for tracking protein oxidation and nitrogen balance. A persistent analytical limitation is that conventional total-nitrogen assays do not deconvolute urinary urea from urinary ammonia, and direct measurement still requires capital-intensive clinical analyzers. Here, we implement and independently validate two cost-effective methods that resolve urinary urea by pairing the presence and absence of urease: Method 1 is a urease-coupled potentiometric assay using an ammonium ion-selective electrode (ISE method); Method 2 is a microplate Berthelot–salicylate colorimetric assay employing a repurposed consumer-grade aquarium ammonia test kit (API®) (API method). Each method was validated against the Roche Cobas C311 clinical analyzer (ISE for urinary ammonia and API for urinary urea) in healthy adult volunteers (n = 10 each), and API–ISE were then compared head-to-head for urinary urea. ISE vs. Cobas yielded R2 = 0.967, slope 95% CI [0.867, 1.173], and Bland–Altman bias of −1.02 mM (95% LoA [−7.40, +5.36] mM). API vs. Cobas yielded R2 = 0.973, slope 95% CI [0.790, 1.039], and bias of −1.55 mM (95% LoA [−11.56, +8.46] mM). API–ISE urinary urea comparison confirmed mutual agreement (R2 = 0.9976, slope 95% CI [0.946, 1.024]; bias of +3.47 mM; 95% LoA [−14.60, +21.53] mM), with mean recoveries near 100% (API: 100.7 ± 2.9%; ISE: 100.6 ± 5.4%; 20–350 mM). Both methods agreed with the clinical analyzer, supporting their potential for decentralized, resource-limited testing; clinical and point-of-care validations are needed.